603077 和邦生物
按盤價 
2.360 +0.060 (+2.609%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 0.501 | 0.165 | 6.633 | 22.820 | 23.779 |
| 總資產報酬率 ROA (%) | 0.316 | 0.116 | 5.276 | 18.117 | 18.483 |
| 投入資產回報率 ROIC (%) | 0.336 | 0.127 | 5.902 | 20.349 | 20.486 | 邊際利潤分析 |
| 銷售毛利率 (%) | 11.237 | 7.801 | 23.261 | 42.853 | 41.379 |
| 營業利潤率 (%) | 3.118 | -0.723 | 17.472 | 34.367 | 35.956 |
| 息稅前利潤/營業總收入 (%) | 3.703 | -0.593 | 17.038 | 34.533 | 36.674 |
| 淨利潤/營業總收入 (%) | 1.290 | -0.828 | 14.491 | 29.222 | 30.303 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 117.218 | -87.226 | 97.559 | 100.124 | 99.254 |
| 價值變動淨收益/利潤總額(%) | -2.475 | 8.633 | 4.897 | 0.487 | 0.753 |
| 營業外收支淨額/利潤總額(%) | -8.442 | 5.924 | -0.379 | -0.058 | -0.355 | 償債能力分析 |
| 流動比率 (X) | 3.066 | 2.605 | 2.685 | 2.603 | 1.487 |
| 速動比率 (X) | 2.114 | 1.760 | 1.485 | 2.047 | 1.195 |
| 資產負債率 (%) | 35.941 | 35.896 | 17.619 | 18.004 | 18.329 |
| 帶息債務/全部投入資本 (%) | 32.167 | 31.270 | 10.403 | 9.686 | 10.540 |
| 股東權益/帶息債務 (%) | 207.167 | 215.943 | 851.542 | 922.881 | 843.249 |
| 股東權益/負債合計 (%) | 175.929 | 175.007 | 452.708 | 440.575 | 433.641 |
| 利息保障倍數 (X) | 4.475 | -3.384 | -46.256 | 186.635 | 43.398 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 42.561 | 37.640 | 35.811 | 17.610 | 18.321 |
| 存貨周轉天數 (天) | 220.824 | 204.380 | 172.228 | 72.187 | 47.515 |
| 備註： | 即時報價更新時間為 05/12/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
